Tuberculosis tests are existing to diagnosis tuberculosis. These tests are used to discover tuberculosis bacteria which are subjected to tuberculosis drug resistant or TB drug treatment. Tuberculosis test are used to determine if someone has infected with tuberculosis bacteria. The expansion of tuberculosis disease is occurring in two stages. In first stage a person contains TB bacteria that are latent TB. In second stage the TB bacteria will reproduced adequately which cause the patient to have become unwell. Analysis of active tuberculosis will be confirmed when there is a distinct confirmation of TB bacteria in the human’s body. Chest X- ray is used when person contains TB bacteria when caused swelling in lungs. Increasing demand for technologically advanced, improved and new TB testing equipment and procedure is the main cause in rise of the TB testing demand.
The Tuberculosis Testing market is expected to exceed more than US$ 3373 million by 2028; growing at a CAGR of more than 4% in the given forecast period.
The major driving factors of tuberculosis testing market are as follows:
Increasing tuberculosis awareness and control events from non government and government.
Increased approval of many tuberculosis testing techniques because of high incidence and occurrence rates of the disease.
Rising demand for many tuberculosis tests.
The restraining factors of tuberculosis testing market are as follows:
Costs of many tuberculosis tests are very high.
The tuberculosis testing market is segmented on the lines of its test type and regional. Based on test type segmentation the tuberculosis testing market covers drug susceptibility testing (DST), radiography (Chest X-Ray), mantoux Test (Tuberculin Skin Test), nucleic acid testing, culture based tests, smear microscopy and other tests such as ADA, IGRA, serological tests etc. The tuberculosis testing market is geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for tuberculosis testing and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for tuberculosis testing
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for tuberculosis testing with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Akonni Biosystems, Inc., Alere, Inc., Becton, Dickinson and Company, bioMérieux SA, Cepheid, Epistem plc, F. Hoffmann-La Roche Ltd., Hain Lifescience GmbH, Hologic, QIAGEN, Sanofi and Thermo Fisher Scientific, Inc.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Tuberculosis Testing Market has been segmented as below:
By Test Type Analysis
Drug Susceptibility Testing (DST)
Radiography (Chest X-Ray)
Mantoux Test (Tuberculin Skin Test)
Nucleic Acid Testing
Culture Based Tests
Smear Microscopy
Other Tests (ADA, IGRA, Serological Tests etc)
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all tuberculosis testing market globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of tuberculosis testing data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
chapter 1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Tuberculosis Testing Market
2.2 Comparative Analysis: Global Tuberculosis Testing Market Revenue, by Geography, 2019 & 2025 (Value %)
Chapter 3 Global Tuberculosis Testing Market Overview
3.1 Introduction
3.1.1 Epidemiology: Tuberculosis
3.1.2 TB Incidence
3.1.3 Diagnosis and Treatment
3.2 Market Drivers
3.2.1 Increased Acceptance of Various TB Testing Techniques due to High Prevalence and Incidence Rates of the Disease Globally
3.2.2 Tuberculosis Awareness and Control Programs from Government and Non-Government Organizations Worldwide Likely to Fuel Growth in Demand for Various TB Tests
3.2.3 Rising Demand for New, Improved, and Technologically Advanced Tuberculosis Testing Procedures and Equipment
3.3 Market Restraints
3.3.1 High Cost of Various Tuberculosis Tests may Affect the Overall Global Demand
3.4 Market Opportunities
3.4.1 Presence of a Huge Potential Market in Most of the Emerging Nations of the World
3.5 Porter’s Five Forces Analysis: Global Tuberculosis Testing Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Value Chain Analysis: Tuberculosis Testing Market
3.7 Market Attractiveness Analysis: Global Tuberculosis Testing Market, by Geography
3.8 Competitive Landscape
3.8.1 Market Share Analysis, by Key Players: Global Tuberculosis Testing Market, 2015 (Value %)
3.8.2 Heat Map Analysis: Global Tuberculosis Testing Market, by Key Players
Chapter 4 Global Tuberculosis Testing Market, by Test Type
4.1 Introduction
4.1.1 Global Tuberculosis Testing Market Revenue, by Test Type, 2019 – 2025 (USD Million)
4.1.2 Comparative Analysis: Global Tuberculosis Testing Market, by Test Type, 2019 – 2025 (Value %)
4.2 Smear Microscopy
4.2.1 Global Smear Microscopy (TB Testing) Market Revenue, 2019 – 2025 (USD Million)
4.3 Culture Based Tests
4.3.1 Global Culture Based Tests (TB Testing) Market Revenue, 2019 – 2025 (USD Million)
4.4 Nucleic Acid Testing
4.4.1 Global Nucleic Acid Testing (TB Testing) Market Revenue, 2019 – 2025 (USD Million)
4.5 Mantoux Test (Tuberculin Skin Test (TST))
4.5.1 Global Tuberculin Skin Tests Market Revenue, 2019 – 2025 (USD Million)
4.6 Radiography (Chest X-Ray)
4.6.1 Global Radiography (Chest X-Ray) Market Revenue, 2019 – 2025 (USD Million)
4.7 Drug Susceptibility Testing (DST)
4.7.1 Global Drug Susceptibility Testing Market Revenue, 2019 – 2025 (USD Million)
4.8 Other Tests (Serological Tests, IGRA, etc.)
4.8.1 Global Other TB Testing Market Revenue, 2019 – 2025 (USD Million)
Chapter 5 Global Tuberculosis Testing Market, by Geography
5.1 Overview
5.1.1 Global Tuberculosis Testing Market Revenue, by Geography, 2019 – 2025 (USD Million)
5.2 North America
5.2.1 North America Tuberculosis Testing Market Revenue, 2019 – 2025 (USD Million)
5.2.2 North America Tuberculosis Testing Market Revenue, by Test Type, 2019 – 2025 (USD Million)
5.3 Europe
5.3.1 Europe Tuberculosis Testing Market Revenue, 2019 – 2025 (USD Million)
5.3.2 Europe Tuberculosis Testing Market Revenue, by Test Type, 2019 – 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Testing Market Revenue, 2019 – 2025 (USD Million)
5.4.2 Asia Pacific Tuberculosis Testing Market Revenue, by Test Type, 2019 – 2025 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 RoW Tuberculosis Testing Market Revenue, 2019 – 2025 (USD Million)
5.5.2 RoW Tuberculosis Testing Market Revenue, by Test Type, 2019 – 2025 (USD Million)
Chapter 6 Recommendations
6.1 Emphasize on Price Control of Various TB Diagnostic Tests
6.2 Focus on Obtaining Increased Government Investments for the Improvement of Laboratory Capacities and Infrastructure
6.3 Target Emerging Markets of Asia Pacific and RoW
Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Akonni Biosystems, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 Alere, Inc.
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 bioMérieux SA
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent developments
7.6 Cepheid
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Epistem Holdings Plc
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Hain Lifescience GmbH
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 F. Hoffmann-La Roche Ltd.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments
7.10 Hologic, Inc.
7.10.1 Company overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments
7.11 Sanofi
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Product Portfolio
7.11.4 Business Strategies
7.11.5 Recent Developments
7.12 Thermo Fisher Scientific, Inc.
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Product Portfolio
7.12.4 Business Strategies
7.12.5 Recent Developments
7.13 QIAGEN
7.13.1 Company Overview
7.13.2 Financial Overview
7.13.3 Product portfolio
7.13.4 Business Strategies
7.13.5 Recent Developments
The Tuberculosis Testing Market has been segmented as below:
By Test Type Analysis
Drug Susceptibility Testing (DST)
Radiography (Chest X-Ray)
Mantoux Test (Tuberculin Skin Test)
Nucleic Acid Testing
Culture Based Tests
Smear Microscopy
Other Tests (ADA, IGRA, Serological Tests etc)
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
